Akitaka Makiyama

Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With <i>RAS</i> Wild-type, Left-Sided Metastatic Colorectal Cancer

Jun Watanabe, Kei Muro, Kohei Shitara et al. · JAMA · 2023 · 222 citations · Full text

Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study)

Akitaka Makiyama, Yasutaka Sukawa, Tomomi Kashiwada et al. · Journal of Clinical Oncology · 2020 · 185 citations

Acute Lymphocytic Myocarditis With Anti-PD-1 Antibody Nivolumab

Tomonori Tadokoro, Eri Keshino, Akitaka Makiyama et al. · Circulation Heart Failure · 2016 · 110 citations · Full text

Vasculitis, Autoimmune Disease, Immunology +6

Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours

Takashi Seto, Taito Esaki, Fumihiko Hirai et al. · Cancer Chemotherapy and Pharmacology · 2013 · 101 citations

Dose-escalation Study, Radiation Medicine, Medicine +10

Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604)

Hiroshi Saeki, Eiji Oki, Tomomi Kashiwada et al. · European Journal of Cancer · 2018 · 97 citations

Her2 Status, Surgical Oncology, Oncology +6